News - Page 41 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

Post published:August 16, 2023
Post category:Press Release

Read more about the article MIND CURE HEALTH INC. (TO BE RENAMED LNG ENERGY GROUP CORP.) ANNOUNCES COMPLETION OF BUSINESS COMBINATION TRANSACTION

MIND CURE HEALTH INC. (TO BE RENAMED LNG ENERGY GROUP CORP.) ANNOUNCES COMPLETION OF BUSINESS COMBINATION TRANSACTION

Post published:August 16, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT

Post published:August 15, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company

Clearmind Medicine Announces Collaboration with CTS Ltd., a Leading Pharmaceutical and Consumer Products Company

Post published:August 14, 2023
Post category:Press Release

Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA; DEA “Open to Considering” Special Registration for Controlled Substances via Telemedicine; Professional Practice Guidelines for PAT; Sage’s Zuranolone Rejection

Post published:August 11, 2023
Post category:Psychedelic Bulletin

Read more about the article Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer

Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer

Post published:August 10, 2023
Post category:Press Release

Read more about the article Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Post published:August 10, 2023
Post category:Press Release

Read more about the article Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

Silo Pharma Engages Clarivate for Intellectual Property and Patent Management

Post published:August 10, 2023
Post category:Press Release

Read more about the article atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

Post published:August 10, 2023
Post category:Press Release

Read more about the article Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023

USA – English

USA – Polski

USA – slovenčina

USA – Français

USA – Deutsch

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023 USA – English USA – Polski USA – slovenčina USA – Français USA – Deutsch

Post published:August 9, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.